Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Kevin Kiermaier

Rays End-Of-Season Notes: Fairbanks, Free Agents, 40-Man

By | at

With the Rays 15-inning marathon loss yesterday, their 2022 season has officially ended. Heavily impacted by the injury bug, including Wander Franco, Tyler Glasnow, Shane Baz, and Mike Zunino, the Rays managed to piece together their fifth consecutive winning season, leading to their fourth-straight playoff appearance. Beginning with a strong April and May going 38-21 (.571 win percentage), by the end of the season the Rays were fighting to hold onto a Wild Card berth, going 14-19 in September and October regular season games, finishing their last eight regular season games 1-7 before being swept by the Guardians in the Wild Card series.

Reliever Pete Fairbanks’s departure from yesterday’s game was likely due to a circulation issue, or possibly Raynaud’s syndrome, in his fingers per Marc Topkin of the Tampa Bay Times. It’s the latest injury for Fairbanks, who has dealt with a right rotator cuff issue, right shoulder inflammation, and a right lat strain since the 2021 season. Making his 2022 debut in mid-July, the righty pitched a 1.13 ERA in a limited 24 innings. On the heels of this strong regular season performance, he was selected to Rays postseason roster, but could not record an out due to the finger injury.

Transitioning to the 2023 season, the Rays have a few notable free agents including starter Corey Kluber, outfielder David Peralta, and catcher Mike Zunino. Kluber joined the Rays on a 1-year, $8MM contract and pitched to a respectable 4.34 ERA in 164 innings (31 starts). The 36-year-old pitched his first full season since 2018 with a below-average 20.2% strikeout rate, but an excellent 3.1% walk rate. Peralta began the season with the Diamondbacks, slashing .248/.316/.460 before being traded to the Rays where his numbers dropped to .255/.317/.335. The Rays picked up Zunino’s $7MM club option for the 2022 season after his strong 2021 season, but the catcher underwent thoracic outlet syndrome surgery in July, ending his 2022 season early. The power-hitting catcher was having a cold start to his season, posting a meager .148/.195/.304 line in 115 at-bats.

Center fielder Kevin Kiermaier is also likely to become a free agent, with the Rays holding a $13MM club option for his 2023 season that they will most likely decline. Kiermaier’s 2022 season ended in early July with a hip injury, with the righty posting a substandard .228/.281/.369 slash line in 206 at-bats.

In addition to these free agents, the Rays currently have 19 players who are arbitration-eligible entering the 2023 season, including bullpen forces Jason Adam, Nick Anderson, and Colin Poche. It is very likely that the team won’t retain all 19 players but will instead opt for non-tendering some of them.

As a whole, the 2022 Rays were marked by a surprisingly weak offense. Likely affected by injuries to key bats, Tampa slumped to a collective .239/.309/.377 batting line in 2022, a far cry from the .250/.327/.424 slash line the team put up during the 2018-2021 seasons. Interestingly, the Rays’ catching fell flat after a strong 2021, likely due to the absence of All-Star Zunino.

Tampa’s 2022 catching core, primarily composed of Francisco Mejia, Rene Pinto, and deadline addition Christian Bethancourt, posted a combined measly .224/.248/.373 line. Comparatively, Rays’ catchers slashed .234/.309/.494 in 2021. This team primarily relied on Zunino who broke out and batted a strong .216/.301/.559 in 2021. With Zunino becoming a free agent following the conclusion of the 2022 season, the Rays may opt to bring the veteran back or search for a new slugging backstop for the 2023 season.

Moving sixty feet, six inches from the Rays’ backstop to the mound, once again injuries severely impacted Tampa Bay’s performance. Starters Glasnow and Baz both dealt with elbow injuries that resulted in Tommy John surgery. At an individual level, only one pitcher made over 30 starts, Kluber, and only four pitchers made over 10 starts. Additionally, similar to Zunino, Kluber is a free agent at the conclusion of the season.

These injuries forced Tampa to continue to rely on their bullpen, with starters pitching the fewest innings in the league (753) to the third-lowest ERA (3.45) and the bullpen pitching the most innings in the league (682 2/3) with a low 3.36 ERA, stranding a hefty 74.3% of base runners. While this strategy worked for the majority of the season, by the end of the season Tampa’s bullpen was beginning to crack. Over their last 51 1/3 innings, the Rays’ bullpen ERA increased to 4.38 ERA, and they only stranded 67.6% of base runners.

Nevertheless, the Rays will look to retool this winter and update their roster in hopes of reaching the playoffs for the fifth-straight season.

Previewing Upcoming Club Option Decisions: American League

By | at

Yesterday, MLBTR checked in on the status of seven players who have vesting options in their contracts for the 2023 season. Each can (or already has) lock in some guaranteed money or the right to opt out of their current deal based on their workload or finish in awards voting this year.

Over the next two days, we’ll turn our attention to players with less of a say over their contractual status. A host of contracts around the league contain club options for 2023. Some of them will be easy decisions one way or the other, while there are others that’ll be more borderline calls. With teams having to make these calls a little over two months from now, it’s worth taking a look at how these players are performing in 2022.

Today, we’ll start with the American League. We’ll follow up with a look at the Senior Circuit tomorrow.

Orioles

Baltimore signed Lyles to a $7MM guarantee last winter, taking the form of a $6MM salary for 2022 and at least a $1MM buyout on next year’s option. He’s been a fine back-end starter, working to a 4.35 ERA across 130 1/3 innings. Lyles has below-average strikeout, swinging strike and ground-ball rates, but he leads the club in innings pitched and is throwing plenty of strikes. He’s also drawn strong reviews for his work in the clubhouse with the team’s younger arms. A $10MM call is borderline for a 4th/5th starter type, but the Orioles have almost nothing on the books next season and could keep him around as a veteran stabilizer.

Red Sox

  • James Paxton, SP (team must decide on consecutive $13MM options this offseason; Paxton would have $4MM player option for 2023 if club declines)

Paxton signed a convoluted deal last winter that reflected his atypical situation. A mid-rotation caliber starter when healthy, he’s made just six starts over the past three years and hasn’t pitched in an MLB game since undergoing Tommy John surgery last April. He’s making $6MM this season and could be a rotation option for a team that’ll see each of Nathan Eovaldi, Michael Wacha and Rich Hill hit free agency. The club will have to decide whether to trigger consecutive $13MM options (essentially a two-year, $26MM pact) this winter. If they decline, Paxton could opt in to a $4MM salary for 2023 or test free agency. How things play out largely depends on how Paxton looks down the stretch. Manager Alex Cora recently told reporters the southpaw will throw a simulated game on Friday and could soon head out on a minor league rehab appearance (link via Chris Cotillo of MassLive).

  • Hirokazu Sawamura, RP (team holds option currently valued at $3.6MM; Sawamura holds player option for 2023 currently valued at $1.8MM if club declines)

Sawamura signed a two-year, $3MM guarantee with the Red Sox over the 2020-21 offseason. The deal also included a club option for 2023 valued anywhere between $3-4MM, depending on whether Sawamura held his roster spot and based on his number of appearances. MLBTR has confirmed that escalators have already pushed the value of the club option to $3.6MM; that price escalates by an additional $100K for reaching each of 45, 50 and 60 appearances this season. (He’s presently at 43 games). If the team declines, Sawamura would have the right to trigger a player option currently valued at $1.8MM. As with the club option, the player option price escalates by $100K for reaching 45, 50 and 60 appearances. If both sides bypass their respective options, Sawamura would receive a $1MM buyout.

It seems likely that Sawamura’s team option price will fall somewhere in the $3.8MM – 3.9MM range, with a $1.8MM gap between the value of the club and player options. That’s an acceptable price to pay for a solid reliever, albeit one who’s been relied upon more in lower-leverage innings. Sawamura has a 3.14 ERA in 97 1/3 innings since coming stateside, striking out a decent 23% of opponents with a strong 51.7% ground-ball rate. He’s had issues throwing strikes consistently, but he’s an affordable power arm for a middle innings group that has been one of the team’s biggest weaknesses. That the Red Sox haven’t given Sawamura much high-leverage work in spite of their bullpen struggles is enough of a red flag to put this one in some doubt, but it seems likelier they’ll keep him around.

Yankees

Severino barely pitched between 2019-21 because of injuries, including a Tommy John recovery. He returned to the rotation this season and pitched to an impressive 3.45 ERA through 16 starts before suffering a lat injury that’ll cost him at least two months. The injury history is a real concern, but Severino still looks like an above-average starter when healthy. He’s averaged around 96 MPH on his fastball, struck out 27.2% of opposing hitters and has a tiny 7.2% walk rate. The Yankees would have to be very pessimistic about his health outlook to buy out his age-29 season, particularly since it’s only a $12.25MM decision once the buyout price is taken into account.

Rays

Kiermaier hit .228/.281/.369 over 221 plate appearances before suffering a season-ending left hip injury. It’s the latest in a long line of major health issues for the 32-year-old, and the Rays are planning to buy out the three-time Gold Glove winner. It’s possible the team tries to circle back at a lower price point, but the career-long Ray is likely to hit the open market for the first time in his career.

Blue Jays

The Jays just acquired Bass from the Marlins at the trade deadline, fortifying their bullpen with a productive middle-innings arm. Bass has an excellent 1.49 ERA through 48 1/3 innings on the year, striking out 26.2% of opponents against just a 5.9% walk rate. It’s a career-best season at age 34, but Bass has a sub-4.00 ERA for five years running. He’s an underrated bullpen piece, and the Jays are sure to bring him back for what amounts to a $2MM decision.

White Sox

This is as easy a call as any team will have to make this winter. Anderson has been one of the game’s better players four years running. He’s an elite contact hitter and baserunner, and he’s cemented himself as the Sox’s franchise shortstop. His 2022 season has been dinged by injuries, including a recent hand ligament tear that’ll cost him most of the remaining schedule. Frustrating year aside, Anderson has hit at a quality .301/.339/.395 clip this season and been an All-Star caliber performer in prior years. The White Sox are keeping him around next year, and they can do the same in 2024 via $14MM option.

Harrison signed a one-year deal in Spring Training and got off to a dreadful start. The veteran utilityman has turned things on since the calendar flipped to June, though, and he now carries a roughly league average .242/.312/.385 line through 281 plate appearances. The Sox will have to make a $4MM call this offseason on whether to bring him back for 2023. They’ll probably look for an upgrade at second base, but that’s a reasonable enough sum to dedicate to a quality infielder off the bench. Chicago already has Leury García making decent money in that role, and they might prefer to focus their finances on adding to the back of the rotation and bringing back star first baseman José Abreu.

Guardians

Shaw is a longtime member of the Cleveland organization, having spent seven of his 11 MLB seasons there. He’s a durable bullpen workhorse who’s clearly a favorite of the coaching staff and front office, but his 2022 results have not been good. The 34-year-old righty owns a 5.36 ERA across 40 1/3 innings. He’s only striking out 17.7% of opponents, walking batters at an elevated 11.6% clip and has had some home run issues. The Guardians seem likely to go in another direction this offseason.

Twins

Sanó is a longtime member of the organization who’s capable of carrying a lineup with his power at his best. His platform season has been a disaster, though, and the Twins are sure to buy out his option. The 29-year-old underwent surgery to repair a meniscus tear in his knee in May. He returned briefly but went back on the 60-day injured list last week with additional knee concerns. It’s not clear whether he’ll make it back this season. Sanó has an .083/.211/.133 line in 20 games this year after slightly above-average offensive performances in 2020-21.

Just as Sanó’s option is certain to be bought out, Gray’s is a no-brainer to exercise. Minnesota acquired the right-hander from the Reds in Spring Training, sending last year’s first-round pick Chase Petty to Cincinnati. Gray lost some time on the injured list, but he’s posted an impressive 3.19 ERA with slightly above-average peripherals through his first 16 starts in a Twins uniform. A mid-rotation starter of his caliber is a solid bargain at the cost of his option, which played into the fairly high asking price the Twins had to relinquish in the trade.

The Twins bought low on Bundy on a one-year free agent deal, hoping he’d rebound from a dismal 2021 and look more like the mid-rotation arm he resembled in 2020. That hasn’t really transpired, as the right-hander has a 5.01 ERA through 93 1/3 innings. He’s averaging a personal-low 89.2 MPH on his fastball, and while he’s throwing plenty of strikes, that lack of velocity has been reflected in both his 18.6% strikeout rate and higher than average home run rate. It seems likely the Twins will decline the option and reallocate that $10MM elsewhere, particularly with the recent acquisition of Tyler Mahle and Kenta Maeda’s expected return reducing the urgency to add to the rotation next season.

Astros

Acquired in a one-for-one deadline swap that sent Jake Odorizzi to Atlanta, Smith is having a generally disappointing year. He has a 4.17 ERA through 41 innings, striking out a personal-worst 24.1% of batters faced with a career-high 11.2% walk rate. Smith was an effective late-game arm as recently as a season ago and is still generating swinging strikes at a quality 14.2% clip, but the $12MM price tag seems likely to be too hefty given the mediocre strikeout and walk numbers.

Athletics

Piscotty has spent five seasons in Oakland after being acquired from the Cardinals heading into the 2018 campaign. He had an excellent first season in green and gold, but he’s been a well below-average hitter fours years running now. Going back to the start of 2019, Piscotty has a .231/.288/.380 line in just under 900 trips to the plate. He’s sure to be bought out and could be looking at minor league offers next winter.

Mariners

  • Ken Giles, RP ($9.5MM option, $500K buyout)

Seattle signed Giles to a two-year deal knowing he’d miss all of 2021 recovering from Tommy John surgery. Unfortunately, hopes of a year two payout have been largely derailed by a finger issue that delayed his season debut and some shoulder tightness that has kept him out of action for the past month. Giles has thrown just 4 1/3 innings in a Seattle uniform, surrendering only one hit but four walks with six strikeouts. He’s averaged 94.8 MPH on his fastball, still solid but down from the 96.9 MPH range he showed during his incredible 2019 season with the Blue Jays. There’s a non-zero chance Giles returns — he’s currently on a rehab assignment in Triple-A — and dominates down the stretch to make Seattle think about the option. For the moment, though, it’s trending towards a buyout.

Rangers

Texas signed the 34-year-old Richards to a one-year guarantee over the offseason, hoping he’d build off the promise he showed in a late-season bullpen stint with the Red Sox. That hasn’t panned out, as he has a 5.35 ERA across 38 2/3 innings of relief. Richards has an excellent 52.1% ground-ball rate, but he’s not missing as many bats as one would like and he’s giving up a lot of hard contact. Texas seems likely to buy him out.

Texas signed Leclerc to an early-career extension in 2019, locking him in after a 1.56 ERA season the year before. He struggled with his control the following season, then missed virtually all of 2020-21 battling elbow issues that eventually culminated in Tommy John surgery. Leclerc returned to the mound in June but has a 4.01 ERA with a personal-low 20.4% strikeout percentage in 24 2/3 innings of generally low-leverage work. He’s still throwing hard and missing plenty of bats with his slider, so there’s a chance Texas takes an optimistic view and keeps him around. His deal also contains a $6.25MM option for 2024, so he’d be under control for multiple seasons if the Rangers are willing to give him a bit of a longer leash. This feels like it could go either way depending on how he performs down the stretch.

The Rangers signing of Calhoun to a one-year deal over the winter hasn’t panned out. He’s hitting .211/.269/.363 through 350 plate appearances and is currently on the injured list with a heel issue. It’s a second straight below-average season for the veteran outfielder, who’ll be 35 in October. The Rangers will almost assuredly decline the option and look elsewhere in right field as they aim for legitimate competitiveness in 2023.

Latest On Kevin Kiermaier

By | at

Rays center fielder Kevin Kiermaier underwent season-ending hip surgery last month, and the outfielder took to Twitter to send a video updating on his recovery and thank fans for the support this week (video link). Within, Kiermaier indicated that the hip issues which ultimately required the surgery have plagued him for the past year and a half. The Rays described the surgery as a procedure to address an impingement and repair a torn labrum, per Marc Topkin of the Tampa Bay Times.

Of course, for many Rays fans, the broader question is whether Kiermaier will suit up in Tampa Bay or with another club next year. Unsurprisingly, both Topkin and Bob Nightengale of USA Today wrote this weekend that the Rays are planning to pay the $2.5MM buyout on Kiermaier’s $13MM club option rather than commit to that weighty guarantee. That was obvious from the moment Kiermaier underwent surgery; it was worth wondering whether the low-payroll Rays would’ve picked up that option even in the event of a generally healthy and productive season.

Kiermaier didn’t address the contract specifically but made sure to mention his fondness for the Tampa area, the Rays organization, the community and the fans who’ve reached out to offer him support as he’s gone through this latest injury. Whether he’ll return to the Rays next year is likely dependent on how several of the organization’s younger options play over the next few months.

Randy Arozarena and Manuel Margot — on the shelf himself due to a knee injury — seem likely to return regardless. Arozarena has not yet even reached arbitration (though could do so as a Super Two player this winter) and thus remains quite affordable. Margot inked a two-year extension spanning the 2023-24 seasons (plus a 2025 team option) not long before Opening Day. Elsewhere on the roster, the Rays have the just-acquired Jose Siri and top prospect Josh Lowe, both of whom have struggled against big league pitching this season. Siri could fill a similar backup role to that of the since-traded Brett Phillips, whereas Lowe entered the season widely viewed as a potential long-term option in the outfield.

From a financial perspective, there ought to be room on the books for Kiermaier, particularly if he’s signing at a reduced rate. The Rays only have about $22MM in guaranteed salary on next year’s ledger, although that does not include a massive arbitration class featuring Tyler Glasnow, Ji-Man Choi, Ryan Yarbrough, Yandy Diaz, Andrew Kittredge, Francisco Mejia, Yonny Chirinos, Jeffrey Springs, Nick Anderson, Jalen Beeks, Harold Ramirez, Pete Fairbanks, JT Chargois, Colin Poche, Ryan Thompson and perhaps, depending on the Super Two cutoff, both Arozarena and Jason Adam. Not all of that group will be tendered a contract — Yarbrough, for instance, could be cut loose or traded elsewhere — but it has the potential to be a pricey group by the Rays’ standards, especially if Arozarena indeed reaches arbitration eligibility.

The 32-year-old Kiermaier has spent parts of ten seasons in the Majors, batting a combined .248/.308/.407 with some of the best glovework of any player in the Majors, regardless of position. The fearless manner in which Kiermaier patrols the outfield (and, presumably, the artificial surface on which he plays half his games) has taken its toll on his body over the years and regularly left Kiermaier sidelined for lengthy stints on the injured list.

Dating back to 2016 (and excluding the shortened 2020 season), Kiermaier has averaged 86 games played per year, missing time along the way with a fractured left hand, a fractured right hip, a torn ligament in his right thumb, a damaged ligament in his other thumb, a sprained left wrist and now this most recent left hip surgery. Even in spite of that huge list of injuries, Kiermaier has the fourth-most Defensive Runs Saved of the 5511 players who’ve stepped onto a Major League field in that span.

Kevin Kiermaier, Mike Zunino To Undergo Season-Ending Surgery

By | at

The Rays will be without two key players for the rest of the season. Manager Kevin Cash told reporters (including Marc Topkin of the Tampa Bay Times and Joe Trezza of MLB.com) that center fielder Kevin Kiermaier has elected to undergo surgery to address a labrum issue with his left hip. Catcher Mike Zunino is also done for the year, as Topkin reports (on Twitter) he’ll need surgery to correct thoracic outlet syndrome. Cash said Kiermaier is expected to be ready for next Spring Training; the longer-term timetable for Zunino remains unclear.

Both Kiermaier and Zunino were already on the 60-day injured list. Kiermaier was initially diagnosed with hip inflammation, while Zunino’s problem was first termed left shoulder inflammation. The team quickly thereafter revealed Zunino may be battling thoracic outlet syndrome, however. He received Botox treatment in hopes of remedying the issue without going under the knife, but that evidently proved unsuccessful. Thoracic outlet surgery has become fairly prevalent for pitchers, with hurlers like Stephen Strasburg, John King, Brendan McKay and Daulton Jefferies requiring the procedure within the past year. It’s been far less common an occurrence for position players.

Kiermaier and Zunino were known to be facing lengthy recovery processes even before today’s news, so there was already a fair bit of urgency for the club to address the vacated center field and catching positions. Tampa Bay already added help in the latter area, bringing in Christian Bethancourt in a deal with the A’s. Neither Bethancourt nor incumbent Francisco Mejía has performed so well the Rays should rule out further upgrades behind the dish, although the market is fairly shallow. Willson Contreras is one of the game’s most obvious trade candidates, but the Cubs will have plenty of interest around the league in perhaps the top rental bat on the market. Bethancourt’s former teammate, Sean Murphy, is drawing attention as a controllable option, although the acquisition cost for three and a half seasons of his services would be even more substantial than the haul required to land Contreras.

Oakland also has one of the better center fielders who could be available, with Ramón Laureano having three-plus seasons of remaining club control. Beyond Laureano, it’s a murky market there as well, with Bryan Reynolds and Cedric Mullins seemingly unlikely to move. The Royals could market Michael A. Taylor to capitalize on perhaps the best season of his career, while the Nationals may be willing to part with Víctor Robles amidst another down year. The Rays are also without Harold Ramírez and Manuel Margot due to injury, leaving them to rely on Josh Lowe and Brett Phillips — neither of whom is doing much at the plate — alongside Randy Arozarena in the outfield.

The deadline outlook will be the most immediate concern for the Tampa Bay front office, but the longer-term ramifications of today’s news could be the end of Kiermaier’s and Zunino’s tenures in Tampa Bay. Each is in the final guaranteed year of his respective contract. The Rays hold a $13MM option on Kiermaier’s services for 2023, but it’s hard to envision the club bringing him back at that sum. The lefty-hitting outfielder had a modest .228/.281/.369 showing over 221 plate appearances on the season. Between his age (32) and another significant lower body injury, one may wonder how much longer he’ll remain one of the sport’s best defensive outfielders.

Zunino, meanwhile, will hit the market coming off one of the more disappointing years of his career. He popped 33 home runs a season ago, leading the Rays to bring him back on a $7MM option. He managed only a .145/.198/.304 showing in 36 games this year. The 31-year-old is among the sport’s top defensive backstops, but the combination of his woeful 2022 numbers and the TOS procedure deals a tough blow to his stock as he heads towards free agency.

Rays’ Harold Ramirez Suffers Broken Thumb

By | at

Rays first baseman/outfielder Harold Ramirez left today’s game after being hit on his hand by a pitch. The club later announced to reporters, including Marc Topkin of the Tampa Bay Times, that he has a broken right thumb and will be re-evaluated in two weeks.

Ramirez, 27, has been somewhat quietly having an excellent breakout season in Tampa. Although he’s only walking 6.1% of the time, he’s also only striking out at a 13.7% clip, producing a batting line of .329/.376/.446. The resulting wRC+ of 141 indicates he’s been 41% better than the league average hitter. Among hitters with at least 250 plate appearances, that’s the 23rd highest mark across the majors, just ahead of Pete Alonso.

While any team would surely suffer to lose that kind of production for a few weeks, it’s especially noteworthy for a Rays team that’s had a host of injuries to deal with, including in the outfield. When Ramirez is inevitably placed on the injured list, he will join Kevin Kiermaier and Manuel Margot. In Kiermaier’s case, his injury has the potential to be season-ending, per Topkin, though more details will come on that after he sees a specialist in the weeks to come. Margot might return at some point this season, but not soon. Even if Ramirez’s thumb is okay in a couple of weeks, he will likely need to get in some rehab work in order to get back into game shape.

That leaves the club with Randy Arozarena, Josh Lowe, Brett Phillips and Luke Raley as their regular outfielders. Arozarena is having another good season, but the rest are all hitting at below-average rates right now, with none of the three producing a wRC+ higher than 71 on the year, coming into today’s game. Brandon Lowe has played outfield in the past but only just returned from the IL in the last couple of days. He played second base yesterday but is the designated hitter today. Vidal Bruján is in the minors and could be recalled, though he also struggled in his MLB action this year, producing a wRC+ of just 41.

Despite all their injury woes, the Rays began today in the top American League Wild Card spot with a record of 50-41, meaning they will likely look to do some buying ahead of the August 2 trade deadline. There were a number of outfielders featured on MLBTR’s recent list of top trade candidates, including Andrew Benintendi, David Peralta, Ian Happ, and many others.

Rays Make Several Roster Moves

By | at

The Rays have made a number of roster moves today. In terms of additions to the active roster, Brandon Lowe was activated from the 60-day injured list and Ryan Yarbrough was recalled from the taxi squad, per Neil Solondz of the Rays (via Twitter). To make room on the 40-man roster for Lowe, centerfielder Kevin Kiermaier was transferred to the 60-day injured list with left hip inflammation. To create the active roster space, Ralph Garza Jr. and Jonathan Aranda were both optioned to Triple-A.

Lowe has been one of the Rays top position players as the organization has surged to prominence over the last couple of seasons. Second base has become a full team effort with Lowe on the shelf. Aranda, Taylor Walls, Vidal Brujan, Yu Chang, and Isaac Paredes all started at the keystone in July. Lowe has been out since May 15 with a lower back injury. Before the injury, he racked up 133 plate appearances with a .212/.293/.415 triple slash line.

For his small part, Aranda stepped in nicely for a seven-game stretch, going 6-for-16 at the plate, striking out three times without taking a walk. It was the first bit of big league action for the 24-year-old infielder.

Yarbrough tossed 34 innings for the Rays earlier this season with a 5.82 ERA/5.35 FIP. The crafty southpaw has been as consistent a presence as the Rays allow over the past five seasons.

In a separate deal, the Rays have claimed Cooper Criswell off waivers from the Angels and optioned him to Triple-A, per Solondz. To make room on the 40-man roster, Shane Baz was transferred to the 60-day injured list. The 25-year-old Criswell made his Major League debut for the Angels last season, making a single start. He has registered a 3.50 ERA through 18 innings in Triple-A this season.

Wander Franco To Miss 5-8 Weeks Due To Hand Surgery

By | at

Rays’ shortstop Wander Franco, who was placed on the IL yesterday due to an injury to his hamate bone, will undergo surgery to repair it. Marc Topkin of the Tampa Bay Times relayed the news, noting that Franco will be out 5-8 weeks.

Long considered one of the top prospects in the sport, Franco debuted last year and delivered on the hype with an excellent rookie campaign. Just 20 years old at the time, he got into 70 games, striking out in just 12% of his plate appearances and hitting .288/.347/.463 for a wRC+ of 127. On the heels of that campaign, the Rays signed him to an 11-year, $182MM extension to keep him around as the face of the franchise for the next decade-plus.

Unfortunately, the first season of that extension hasn’t gone according to plan, with Franco being beset by injuries on multiple occasions. He first landed on the IL in May due to a quad strain, before this hamate injury surfaced. He’s managed to get into 58 games on the season, but seems to have been dragged down by these ailments. His batting line this year is .260/.308/.396, still above average with a 104 wRC+, but surely a disappointment for a young player hoping to see year-over-year growth. With a 5-8 week absence coming up, it seems he won’t be back until mid-August at the earliest, but potentially not returning until September.

The grim news for the Rays doesn’t end there, as Topkin relays an update on center fielder Kevin Kiermaier, who also went on the IL yesterday alongside Kiermaier. Manager Kevin Cash says that Kiermaier will see a hip specialist after the All-Star break and is going to be “down for some time.” The defensive wiz was having another one of his customary seasons, providing quality glovework while hitting just shy of league average. While the length of his absence isn’t exactly clear, it seems like it will be significant. This leaves the club doubly handicapped in the outfield, especially in center, as Manuel Margot is also on the IL, with a patellar tendon strain keeping him out of action for a decent chunk of time as well.

With Franco out of action in the past couple of days, the club has turned to Taylor Walls at shortstop. Through 73 games this year, he’s hitting just .164/.245/.264 for a wRC+ of 52. Center field has been manned by Brett Phillips, who’s hitting .146/.218/.247 for a 39 wRC+ on the campaign. With both Franco and Kiermaier out of action for significant time, these two areas stand out as clear areas of need as the August 2 trade deadline approaches. The Rays are currently 45-40, well back of the Yankees in the AL East but still in possession of a postseason spot in a tight Wild Card race.

East Notes: Castillo, Jays, Orioles, Marte, Kiermaier, Nationals

By | at

Luis Castillo was a Blue Jays trade target last winter, and unsurprisingly, Toronto continues to have interest in Castillo’s services, according to USA Today’s Bob Nightengale.  Though Castillo missed the first month of the season due to shoulder soreness, he has been in strong form with a 2.92 ERA over 71 innings, even if his Statcast numbers aren’t quite as reflective of top-notch performance.  Castillo’s walk rate and hard-contact numbers are only okay, though his strikeout rate (25.3%) is well above league average and he still has elite fastball velocity.

The Reds right-hander is one of the very best players (let alone pitchers) expected to be available as the deadline approaches, making him a natural fit for a Toronto club in sore need of pitching upgrades.  Between Hyun Jin Ryu’s Tommy John surgery and underwhelming performances from Jose Berrios and Yusei Kikuchi, the faulty rotation has been the chief reason for the Jays’ struggles in the last month, which is why Nightengale writes that the Blue Jays “are expected to be the most aggressive team pursuing starting pitching help.”  Last summer’s trade for Berrios is an example of how the Toronto front office hasn’t been hesitant to pay a big price for a player they want and need, though the Blue Jays will face plenty of competition for Castillo’s services.

More from both the AL East and NL East…

  • Also from Nightengale, the Orioles’ surprisingly strong play seemingly hasn’t changed the club’s long-term plans, as Baltimore is “expected to unload” several notable veterans.  The list of names includes both impending free agents like Trey Mancini, Rougned Odor, and Jordan Lyles, plus more controllable players like Anthony Santander and All-Star closer Jorge Lopez.  It’s safe to assume that the price tag will be a lot higher for Lopez and Santander than the others, but regardless, the O’s likely aren’t going to change course and start thinking about a playoff push.
  • Starling Marte left Saturday’s game due to a groin injury, and Marte wasn’t in the Mets lineup on Sunday.  However, Marte is only day-to-day, as manager Buck Showalter told reporters (including MLB.com’s Anthony DiComo) that an MRI revealed only minor inflammation and no serious damage.  Marte has been a big contributor in his first year in New York, and his first-half performance earned him a slot on the NL All-Star team earlier today.  With this groin injury lingering, however, Marte might opt to skip the game to rest up over the break.
  • Kevin Kiermaier was placed on the 10-day injured list earlier today, marking the second time this month that a nagging hip injury has put the Rays outfielder on the shelf.  Kiermaier told reporters (including Marc Topkin of the Tampa Bay Times) that he received a cortisone shot during his first IL stint, but now that the issue has returned, he’ll be visiting a specialist to further explore the injury.  “There’s just a lot of unknowns right now with what’s to come….I don’t really know what the future holds, to be quite honest,” Kiermaier said, noting that surgery was a possibility.  A major procedure could quite possibly end Kiermaier’s season, and thus maybe his tenure with the Rays altogether, as 2022 is the final guaranteed year of his contract.  Kiermaier has spent all 13 of his pro seasons in the Tampa organization, though that tenure has involved several injury absences.
  • There hasn’t been much public information revealed about the Nationals’ possible sale, but billionaire Michael B. Kim is the first name linked to the list of potential buyers, according to Barry Svrluga and Chelsea Janes of The Washington Post.  Kim and another bidding group have met in person with team officials already, and a third group is also slated for in-person meetings later in July.  Though there seems to be an increasing feeling that the Lerner family will indeed sell the Nationals, it is still early in the process, since “as many as five or six individuals or groups are expected to meet with club officials.”

Rays Place Wander Franco, Kevin Kiermaier, Jeffrey Springs Injured List

By | at

July 10: The Rays have officially announced that Franco and Kiermaier have been placed on the 10-day IL, while lefty Jeffrey Springs has been placed on the 15-day IL due to right lower leg tightness. Righty Calvin Faucher was also optioned to Triple-A Durham. To take over those four spots on the roster, they have indeed recalled Raley and Aranda, as well as lefty Josh Fleming and righty Phoenix Sanders.

July 9: The Rays have lost two regulars to the 10-day injured list, as Wander Franco and Kevin Kiermaier have both been sidelined.  As reported earlier, Franco left today’s game due to an injury in his right hand and wrist area, and manager Kevin Cash told reporters (including Marc Topkin of the Tampa Bay Times) that the initial diagnosis is that the injury is related to Franco’s hamate bone.  Franco will visit doctors on Monday to determine the extent of the problem, and if surgery is required, he could miss roughly 6-8 weeks.

Franco had to be removed after his very first at-bat, a first-inning strikeout against Hunter Greene.  On the second-last pitch of the plate appearance, Franco looked shaken up after fouling off a Greene fastball, and he was replaced in the field for the bottom of the inning.

Kiermaier played most of Saturday’s 5-4 loss to the Reds, as the center fielder was replaced for a pinch-runner after singling in the ninth inning.  During the game, however, Kiermaier experienced more discomfort in his left hip — that same issue forced Kiermaier to the IL in late June, though he missed only the minimum 10 days before being activated.

Given the recurring nature of the hip problem, it seems likely that Kiermaier will miss more than 10 days, though the upcoming All-Star break could cover four days of that IL stint.  Unless the Rays want to monitor Kiermaier to ensure that the hip soreness is entirely behind him, Kiermaier could be activated as early as July 22, when the Rays kick off their second half with a series in Kansas City.

Even if Franco can avoid surgery, he’ll still need at least a few weeks of recovery time.  The second-year star has hit .260/.308/.396 over 247 plate appearances this season — still above-average (1o4 wRC+) production, but naturally a letdown given the high expectations created by Franco’s top-prospect status and excellent 2021 rookie season.  Franco got off to a great start before quad injuries hampered his play in May, and that quad problem eventually sent him to the IL for four weeks.

Topkin writes that outfielder Luke Raley and infielder Jonathan Aranda are likely to be called up to replace Franco and Kiermaier on the active roster.  Aranda made his MLB debut in cup-of-coffee fashion earlier this season, playing in two games.  He’ll likely step into Taylor Walls’ utility infield role, as Walls will probably resume everyday shortstop duty (as he did during Franco’s last IL stint).

Raley is also a left-handed hitting outfielder, so in that sense, he’s an easy replacement for Kiermaier in Tampa Bay’s outfield mix.  However, there’s obviously no way to easily replace Kiermaier’s all-world defense, though backup Brett Phillips is a solid defender in his own right (even if right field is Phillips’ best outfield position from a glovework standpoint).  Phillips and Josh Lowe are the likeliest candidates to handle center field while Kiermaier is out, and Vidal Brujan also figures to chip in up the middle.  Manuel Margot is out until at least late August due to a patellar tendon strain, and while the Rays are optimistic Margot will play again in 2022, anything he can contribute going forward might be seen as a bonus.

While neither Franco or Kiermaier have excelled at the plate this season, their twin absences will likely only intensify the Rays’ already clear need for more hitting help at the deadline.  Especially if Franco is sidelined until September, Tampa will need more consistent production from the lineup if the team is going to both qualify for the postseason and then be legitimate contenders in October.  As usual, the Rays aren’t likely to break the bank on a new acquisition, but position-player depth (whether an everyday name or a multi-positional part-timer) certainly seems like a priority.

Latest On Manuel Margot

By | at

June 22: Cash provided a fairly positive update on Margot Wednesday, telling reporters the early testing results “are looking better than not” (Topkin link). He’s facing an extended absence in any event and a specific timetable won’t be known until the club has an official diagnosis, but Cash indicated Margot could still return this season.

June 21: Tampa Bay has placed both Margot and Kiermaier on the injured list. Infielder Jonathan Aranda is up for his Major League debut, and outfielder Luke Raley has been recalled as well.

Topkin tweeted this morning that the team expects Margot’s absence to be “significant,” and Jim Bowden of The Athletic suggests there are those in the organization who fear an ACL injury to Margot. The Rays announced that the results of Margot’s MRI are still pending and are continuing to refer to it as a “knee sprain” for the time being.

June 20: The Rays are likely to place outfielders Manuel Margot and Kevin Kiermaier on the 10-day injured list, manager Kevin Cash told reporters (including Marc Topkin of the Tampa Bay Times). Both players made early exits from tonight’s loss to the Yankees, and Margot in particular seems to be facing an extended absence.

Margot had to be carted off the field in the top of the ninth inning. Playing right field, he leaped into the wall in pursuit of an Aaron Hicks fly ball. He landed awkwardly on his right knee after the collision and had to be carted off the field. Cash said after the game he’s been diagnosed with a knee sprain and ominously noted “it doesn’t look good.”

Kiermaier, meanwhile, departed after the second inning. The team later announced he was dealing with inflammation in his left hip, and that issue will apparently require he miss at least a week and a half. It marked the second time in five days that Kiermaier had to make an early exit, and while his latest issue is different than the Achilles inflammation that forced his departure last Wednesday, it’ll lead to an absence of some kind.

Needless to say, the loss of a couple regular outfielders will force Tampa Bay to dip into its depth. Randy Arozarena has started at designated hitter in each of the past two nights, but he’ll now head back to left field on a more or less everyday basis. Highly-regarded rookie Josh Lowe was recalled before tonight’s game after a six-week stint in Triple-A Durham. He figures to assume regular reps in either center or right field, but it remains to be seen how much of an offensive impact he’ll make. The 24-year-old has only a .179/.257/.328 line through his first 75 MLB plate appearances; he posted big numbers with the Bulls but also struck out at an alarming 31.2% rate in the minors.

Tampa Bay has a pair of out-of-options backup outfielders on the active roster in Brett Phillips and Harold Ramírez. Both players could assume larger roles with Margot and Kiermaier out, but each would probably be miscast as an everyday player. Phillips is an excellent defender but is hitting .172/.238/.291 with a 41.6% strikeout rate. Ramírez is performing at the plate (.297/.337/.386) but has rated as a well below-average defender throughout his career.

The Rays could turn to a loose platoon arrangement between the left-handed hitting Phillips and the righty-swinging Ramírez in right field with Lowe playing center, particularly if they anticipate Kiermaier’s absence being on the shorter side. Former Dodger Luke Raley is on the 40-man roster and hitting well in Durham, and he could be recalled to add some offense-first bench depth. It seems likely the club will at least poke around the market for potential external additions, though, considering the amount of uncertainty with each of Lowe, Phillips, Ramírez and Raley.

It has been a rough stretch for the Rays, who’ve been without their primary middle infield of Brandon Lowe and Wander Franco and their #1 backstop Mike Zunino for weeks. The losses of Margot and Kiermaier will leave the club without five of their regular position players, and it’s little surprise the team has sputtered of late. Tampa Bay has dropped six of their past seven games to fall to 36-31. They now sit a half-game back of the Red Sox for the final Wild Card spot in the American League.

The rough injury news wasn’t limited to what happened tonight, as Cash also provided a discouraging update on reliever Nick Anderson pregame. The right-hander has been on the IL all season after undergoing a UCL brace procedure last October. His initial recovery timeline suggested a possible return around the All-Star Break, but Cash said he’s still feeling elbow discomfort and will go for further evaluation tomorrow (Topkin link). More will obviously be known in the coming days, but it seems unlikely the 31-year-old will be back on a major league mound in the near future.

Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

hide arrows scroll to top